[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.107.222. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Download PDF
Figure 1.
Patient with boxcar and rolling acne scars before (A) and after (B) treatment.

Patient with boxcar and rolling acne scars before (A) and after (B) treatment.

Figure 2.
Patient with rolling and excoriation acne scars before (A) and after (B) treatment. The hypopigmentation associated with the excoriation scars persisted after treatment as anticipated; however, the depth of these scars is significantly diminished.

Patient with rolling and excoriation acne scars before (A) and after (B) treatment. The hypopigmentation associated with the excoriation scars persisted after treatment as anticipated; however, the depth of these scars is significantly diminished.

Table 1. 
Evaluators A and B and Patient Self-assessment—Overall Result*
Evaluators A and B and Patient Self-assessment—Overall Result*
Table 2. 
Evaluator C—Extent of Scarring by Type*
Evaluator C—Extent of Scarring by Type*
Table 3. 
Summary of Results by Scar Type*
Summary of Results by Scar Type*
Table 4. 
Separation of Results—Laser and Chemical Peel*
Separation of Results—Laser and Chemical Peel*
1.
Kellett  SCGawkrodger  DJ The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999;140273- 282
PubMedArticle
2.
Carniol  PJ Laser resurfacing technique: feathertouch, silktouch, and suretouch resurfacing lasers. Carniol  PJedLaser Skin Rejuvenation. Philadelphia, Pa Lippincott-Raven1998;121
3.
Bridenstine  JBCarniol  PJ Managing post resurfacing complications. Carniol  PJedLaser Skin Rejuvenation. Philadelphia, Pa Lippincott-Raven1998;243- 260
4.
Hardaway  CARoss  EVBarnette  DJ Nonablative cutaneous remodeling with a 1.45 micron mid-infrared diode laser: phases I and II. J Cosmet Laser Ther 2002;43- 8
PubMedArticle
5.
Tanzi  ELAlster  TS Treatment of atrophic facial acne scars with a dual-mode Er:YAG laser. Dermatol Surg 2002;28551- 555
PubMed
6.
Patel  NClement  M Selective nonablative treatment of acne scarring with 585-nm flashlamp pulsed dye laser. Dermatol Surg 2002;28942- 945
PubMed
7.
Tanzi  ELAlster  TS Comparison of a 1450-nm diode laser and a 1320-nm Nd:YAG laser in the treatment of atrophic facial scars: a prospective clinical and histologic study. Dermatol Surg 2004;30152- 157
PubMed
8.
Rogachefsky  ASHussain  MGoldberg  DJ Atrophic and a mixed pattern of acne scars improved with a 1320-nm Nd:YAG laser. Am Soc Dermatol Surg Inc 2003;905- 906
9.
Friedman  PMSkover  GRPayonk  GGeronemus  RG Quantitative evaluation of nonablative laser technology. Semin Cutan Med Surg 2002;21266- 273
PubMedArticle
10.
Goldberg  DJRogachefsky  ASSilapunt  S Nonablative laser treatment of facial rhytids: a comparison of 1450-nm diode laser treatment with dynamic cooling alone. Lasers Surg Med 2002;3079- 81
PubMedArticle
11.
Paithankar  DYRoss  EVSaleh  BABlair  MA  Graham Acne treatment with a 1,450 nm wavelength laser and cryogen spray cooling. Lasers Surg Med 2002;31106- 114
PubMedArticle
12.
Lee  JBChung  WGKwahck  HLee  KW Focal treatment of acne scars with trichloroacetic acid: chemical reconstruction of skin scars method. Dermatol Surg 2002;281017- 1021
PubMed
13.
Al-Waiz  MMAl-Sharqi  AI Medium-depth chemical peels in the treatment of acne scars in dark-skinned individuals. Dermatol Surg 2002;28383- 387
PubMed
14.
Jacob  CIDover  JSKaminer  MS Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol 2001;45109- 117 July
PubMedArticle
15.
Tanzi  ELWilliams  CMAlster  TS Treatment of facial rhytides with a nonablative 1450 nm diode laser: a controlled clinical and histologic study. Dermatol Surg 2003;29124- 128
PubMed
16.
Goldberg  DJRogachefsky  ASSilapunt  S Non-ablative laser treatment of facial rhytides: a comparison of 1450-nm diode laser treatment with dynamic cooling as opposed to treatment with dynamic cooling alone. Lasers Surg Med 2002;3079- 81
PubMedArticle
17.
Menaker  GMMoy  RL Treatment of facial rhytids with a nonablative laser: a clinical and histologic study. Dermatol Surg 1999;25440- 444
PubMedArticle
18.
Leffell  DJ Clinical efficacy of devices for nonablative photorejuvenation. Arch Dermatol 2002;1381503- 1508
PubMedArticle
Original Article
July 2005

Evaluation of Acne Scar Treatment With a 1450-nm Midinfrared Laser and 30% Trichloroacetic Acid Peels

Author Affiliations
 

Author Affiliations: Dr Carniol is in private practice in Summit, NJ. Mr Vynatheya is a student at the University of Pennsylvania, Philadelphia. Mr Carniol is a student at Boston University, Boston, Mass.

Correspondence: Paul J. Carniol, MD, Medical Arts Bldg, 33 Overlook Rd, Suite 202, Summit, NJ 07901 (PJClaser@aol.com).

Arch Facial Plast Surg. 2005;7(4):251-255. doi:10.1001/archfaci.7.4.251
Abstract

Objective  To evaluate the efficacy of treatment of established acne scars with a sequential combination of treatment using a 1450-nm, midinfrared, nonablative diode laser with dynamic cooling spray and 30% trichloroacetic acid peels.

Methods  In this prospective study 9 patients with atrophic rolling, boxcar, or both types of scars received 4 monthly treatments using a 1450-nm, midinfrared, nonablative, diode laser with dynamic cooling spray followed by 2 bimonthly treatments with 30% trichloroacetic acid peels. Blinded evaluators and the patients rated the results.

Results  The group of patients in this study had a greater improvement in their acne scars than has been reported for nonablative laser treatments by other authors. Comparing the results of treatment 2 months after the laser treatments with 2 months after the chemical peels, the patients had a greater improvement after the additional chemical peels. There were no complications in this study. The patients were able to continue all of their regular activities throughout the study.

Conclusion  This sequential treatment regimen using the 1450-nm, midinfrared, nonablative diode laser with dynamic cooling spray and 30% trichloroacetic acid peels produced a noticeable improvement in the acne scars without any associated morbidity.

Acne is a common disorder, which affects the vast majority of people usually between the ages of 11 and 30 years. Many of the affected individuals develop noticeable scarring that typically persists unless it is treated. These facial scars can lead to embarrassment and loss of self-esteem,1 and they may also inhibit interpersonal interactions.

In the past, treatment of acne scars frequently involved ablative modalities such as dermabrasion or laser resurfacing that, while improving the appearance of the scars,2 have associated prolonged recovery, morbidity, and risks of complications.3-5 More recently, physicians have started to use nonablative lasers for treatment of these scars.6-10

Historically, most patients will not have their scars treated. This may be owing to not wanting to deal with the associated risks of the more familiar ablative procedures. They also may not have the available time required for the prolonged recovery from these procedures. Recently, nonablative, collagen-stimulating lasers have become available to treat acne scars.6-10 Because the epidermal injury is minimized with these lasers, they do not have the associated prolonged recovery that occurs with resurfacing lasers. These nonablative lasers are designed to spare the epidermis and stimulate the dermis to produce new collagen.

Using this type of technology alone, the improvements seen on the skin surface are a reflection of the effects on the dermal collagen below.11 This limits the amount of visible improvement. It is our hypothesis that to maximize the visible improvement from nonablative lasers the upper layer of the skin must also be treated.12-13

This study was designed to assess the results that could be achieved by sequentially combining 2 modalities. The first modality used was the 1450-nm, midinfrared, nonablative diode laser with dynamic cooling spray (SmoothBeam; Candela Corporation, Wayland, Mass). This laser exerts its effect on the dermis between 100 and 500 μm of depth. In subsequent treatments, 30% trichloroacetic acid peels were used to treat the upper 100 μm of skin. By combining these 2 modalities both the skin surface and the underlying dermis are treated to improve the acne scars with minimal “down time” for the patients.

METHODS

Ten patients were enrolled in the study. Nine of 10 patients completed the study. One patient did not complete all of the required treatments owing to schedule conflicts and, therefore, is excluded from these data. Patients with only sharply marginated scars, such as ice pick scars as well as patients with hypertrophic scars were not enrolled in the study. Patients with significant rolling or boxcar scars14 were included. Additionally, all patients were Fitzpatrick skin types II and III. Initially each patient’s scars were rated for the types of scars and the extent of scarring on a 0- to 10-point scale. Digital photographs were taken before any treatment was initiated, 2 months after the laser treatment was completed, and 2 months after the chemical peels at the completion of the study. These photographs were used by the blinded evaluators to assess the results. The evaluators were independent in that they did not participate in conducting the study and did not know the patients.

The patients studied had multiple acne scars for years. As is typical for well-established scars, the scars would persist with minimal or no change without intervention. As such, each patient’s baseline was used as their own control.15 Furthermore, as part of the posttreatment evaluation, the before and after photographs were randomized and unlabeled. Thus, each of the 2 evaluators first had to distinguish between the pretreatment and posttreatment photographs and then assess the improvement.

Each patient was enrolled in the treatment protocol. This protocol and study were reviewed, followed up, and approved by the Western Institutional Review Board, Olympia, Wash, throughout the course of the study.

Patients first received a series of 4 monthly treatments with the midinfrared 1450-nm nonablative diode laser with dynamic cooling spray (SmoothBeam). Before each treatment 4% lidocaine hydrochloride (LMX4; Ferndale Laboratories, Ferndale, Mich) was first applied for topical anesthesia for at least 45 minutes. Test spots were then made and the patient’s skin was observed for 15 minutes. If the patient tolerated the test spots well, the treatment was then performed. The laser was used at a fluence of 12 to 13 J/cm2. The dynamic cooling spray varied from 30 to 40 milliseconds. Each patient received 4 laser treatments at monthly intervals. Two months after the fourth laser treatment, the first 30% trichloroacetic acid peel was performed. Two months later a second 30% trichloroacetic acid peel was performed. Two months after the second peel the final evaluation was performed.

Photographs were taken after the laser treatments were completed, before the first trichloroacetic acid peel, and at the final evaluation 2 months after the second chemical peel. At that time the patients were asked to evaluate the results. Two blinded evaluators compared and rated the photographs that were taken at the beginning and end of the study. After identifying the pretreatment and posttreatment photographs, they were asked to rate the results, using a 0- to 10-point scale. A third, blinded evaluator (J.V.) analyzed the results after the laser treatments and after the chemical peels to assess the relative contribution of each modality.

RESULTS

Regardless of the extent and type of scarring, all of the study patients had noticeable improvement in the appearance of their acne scars as rated by both the evaluators and the patients who participated in the study. The amount of improvement was readily visible in that the evaluators were readily able to distinguish unlabeled prestudy and poststudy photographs (Figure 1 and Figure 2).

Figure 1.
Patient with boxcar and rolling acne scars before (A) and after (B) treatment.
Patient with boxcar and rolling acne scars before (A) and after (B) treatment.

Figure 2.
Patient with rolling and excoriation acne scars before (A) and after (B) treatment. The hypopigmentation associated with the excoriation scars persisted after treatment as anticipated; however, the depth of these scars is significantly diminished.
Patient with rolling and excoriation acne scars before (A) and after (B) treatment. The hypopigmentation associated with the excoriation scars persisted after treatment as anticipated; however, the depth of these scars is significantly diminished.

The patients consistently noted a significant improvement. Their mean improvement self-assessment score was6.4 on a scale of 0 to 10, with an SD of 2.18 and a median of 7.

Independent evaluators also assessed the patients’ results on a scale of 0 to 10. Between the 2 evaluators, the mean (SD) improvement of all the patients was 6.8 (1.1) with a median of 7. This is similar to the patients’ assessments. The evaluators were unaware of the patient’s opinions about their results.

Results were also assessed based on the type of scarring evident in each patient. Mean values of the extent of scarring (rated from 0-10) by type of scar (rolling, boxcar, or both) were calculated before and after the entire treatment. By subtracting these values, the mean improvement of each was determined. The mean improvement of rolling scars was 5.3 while the mean improvement of boxcar scars was 1.5. Although it is evident that the combination laser and chemical peel treatments had a greater effect on rolling scars, boxcar scars were also significantly improved.

Finally, to evaluate the efficacy of the 1450-nm, midinfrared, nonablative diode laser and the 30% trichloroacetic acid peel separately, additional assessments of the extent of scarring were performed by another independent evaluator (J.V.) after the laser treatment and before the chemical peel. These assessments were also separated according to type of scarring. Differences between these intermediate assessments and initial and final assessments determined the laser’s relative contribution and the chemical peel’s relative contribution to overall improvement. For rolling scars, there was an improvement of 4.3 points with the laser and an additional 1.0 point with the chemical peel. For boxcar scars, results showed an improvement of 1.2 points with the laser and an additional 0.3 of a point with the chemical peel. As the aforementioned results illustrate, the chemical peel provides an essential, additional amount of improvement (Table 1, Table 2, Table 3, and Table 4).

COMMENT

All of the patients in this study had a noticeable improvement in their acne scars and were pleased with the results of this combined therapy. This was both on their subjective evaluations as well as the independent evaluations. The percentage of improvement was greater than has been reported for nonablative lasers alone.7-8 The improvement in acne scars was also comparatively greater than has been reported for nonablative laser treatment of rhytids.16-18 Three of the patients were so pleased with the results that they requested additional laser and chemical peel treatments beyond the study. The 4 laser treatments consistently produced a noticeable improvement. The subsequent chemical peels consistently yielded additional improvement. As described, these chemical peels were relatively superficial as the goal was only to treat just beyond the superficial 100 μm of the skin that was not directly treated by the laser. This differs from studies treating acne scars with chemical peels in which the peels were significantly deeper.12-13 Typically after this chemical peel the patients developed 1 to 4 days of superficial crusting, which did not limit their activities, followed by 1 to 4 days of mild pinkness.

There were no significant complications in any of the study patients or in the one patient who did not complete the study. However, previous studies with nonablative lasers have reported problems such as procedural pain and hyperpigmentation.7, 17 The lack of procedural pain was due to the application of 4% lidocaine hydrochloride at least 45 to 60 minutes before treatment with the laser. All of the patients were able to continue their regular activities throughout the study, as there was no associated morbidity.

CONCLUSIONS

Significant improvement in the appearance of atrophic acne scars can be achieved with a sequential temporally staged regimen using the 1450-nm, midinfrared, nonablative diode laser and 30% trichloroacetic acid peels. In this study there was no associated morbidity and, therefore, the patients did not lose any time from their regular activities. Considering these results, 1 of us (P.J.C.) prefers this regimen to resurfacing modalities for the treatment of acne scars. In the future as other technology or techniques become available, this may change.

AUTHOR INFORMATION

Correspondence: Paul J. Carniol, MD, Medical Arts Bldg, 33 Overlook Rd, Suite 202, Summit, NJ 07901 (PJClaser@aol.com).

Accepted for Publication: March 2, 2005.

Funding/Support: This study was supported in part by the Candela Corporation, Wayland, Mass.

References
1.
Kellett  SCGawkrodger  DJ The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999;140273- 282
PubMedArticle
2.
Carniol  PJ Laser resurfacing technique: feathertouch, silktouch, and suretouch resurfacing lasers. Carniol  PJedLaser Skin Rejuvenation. Philadelphia, Pa Lippincott-Raven1998;121
3.
Bridenstine  JBCarniol  PJ Managing post resurfacing complications. Carniol  PJedLaser Skin Rejuvenation. Philadelphia, Pa Lippincott-Raven1998;243- 260
4.
Hardaway  CARoss  EVBarnette  DJ Nonablative cutaneous remodeling with a 1.45 micron mid-infrared diode laser: phases I and II. J Cosmet Laser Ther 2002;43- 8
PubMedArticle
5.
Tanzi  ELAlster  TS Treatment of atrophic facial acne scars with a dual-mode Er:YAG laser. Dermatol Surg 2002;28551- 555
PubMed
6.
Patel  NClement  M Selective nonablative treatment of acne scarring with 585-nm flashlamp pulsed dye laser. Dermatol Surg 2002;28942- 945
PubMed
7.
Tanzi  ELAlster  TS Comparison of a 1450-nm diode laser and a 1320-nm Nd:YAG laser in the treatment of atrophic facial scars: a prospective clinical and histologic study. Dermatol Surg 2004;30152- 157
PubMed
8.
Rogachefsky  ASHussain  MGoldberg  DJ Atrophic and a mixed pattern of acne scars improved with a 1320-nm Nd:YAG laser. Am Soc Dermatol Surg Inc 2003;905- 906
9.
Friedman  PMSkover  GRPayonk  GGeronemus  RG Quantitative evaluation of nonablative laser technology. Semin Cutan Med Surg 2002;21266- 273
PubMedArticle
10.
Goldberg  DJRogachefsky  ASSilapunt  S Nonablative laser treatment of facial rhytids: a comparison of 1450-nm diode laser treatment with dynamic cooling alone. Lasers Surg Med 2002;3079- 81
PubMedArticle
11.
Paithankar  DYRoss  EVSaleh  BABlair  MA  Graham Acne treatment with a 1,450 nm wavelength laser and cryogen spray cooling. Lasers Surg Med 2002;31106- 114
PubMedArticle
12.
Lee  JBChung  WGKwahck  HLee  KW Focal treatment of acne scars with trichloroacetic acid: chemical reconstruction of skin scars method. Dermatol Surg 2002;281017- 1021
PubMed
13.
Al-Waiz  MMAl-Sharqi  AI Medium-depth chemical peels in the treatment of acne scars in dark-skinned individuals. Dermatol Surg 2002;28383- 387
PubMed
14.
Jacob  CIDover  JSKaminer  MS Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol 2001;45109- 117 July
PubMedArticle
15.
Tanzi  ELWilliams  CMAlster  TS Treatment of facial rhytides with a nonablative 1450 nm diode laser: a controlled clinical and histologic study. Dermatol Surg 2003;29124- 128
PubMed
16.
Goldberg  DJRogachefsky  ASSilapunt  S Non-ablative laser treatment of facial rhytides: a comparison of 1450-nm diode laser treatment with dynamic cooling as opposed to treatment with dynamic cooling alone. Lasers Surg Med 2002;3079- 81
PubMedArticle
17.
Menaker  GMMoy  RL Treatment of facial rhytids with a nonablative laser: a clinical and histologic study. Dermatol Surg 1999;25440- 444
PubMedArticle
18.
Leffell  DJ Clinical efficacy of devices for nonablative photorejuvenation. Arch Dermatol 2002;1381503- 1508
PubMedArticle
×